Table 2.
Barriers | Frequency | % of total (N = 55) * |
---|---|---|
HBV Screening Barriers | 29 | 52.73 |
Insurance | 14 | 25.4 |
Competing Priorities | 13 | 23.6 |
Guideline Complexity | 8 | 14.5 |
Concern for Patient Infection Management | 7 | 12.7 |
Difficulty Discussing Risk Factors | 7 | 12.7 |
HBV Vaccination Barriers | 35 | 63.6 |
Patient Hesitancy | 24 | 43.6 |
Challenges with Multiple Doses | 18 | 32.7 |
Insurance | 10 | 18.2 |
Cost | 6 | 10.9 |
Competing Priorities | 6 | 10.9 |
HDV Screening Barriers | 29 | 52.7 |
Knowledge of Tests | 18 | 32.7 |
Insurance | 10 | 18.2 |
Guideline Complexity | 9 | 16.4 |
Table 2 outlines barriers reported by providers in provision of various aspects of HBV and HDV care. * Research role excluded from these results